Johnson & Johnson vaccine recommended for Canadians 30 and older despite risk of rare blood clots
2021-05-03 from cbc.ca
The Johnson & Johnson vaccine is now recommended for all Canadians 30 years of age and older, but officials say to weigh the risk of rare but potentially serious blood clots that can occur from the vaccine with COVID-19 levels in the community — or hold out for another shot altogether.
The National Advisory Committee on Immunization (NACI) said Monday that while the Johnson & Johnson vaccine will soon be distributed across Canada, it's up to Canadians in that age group to decide whether they should take it or wait for an mRNA vaccine such as Pfizer-BioNTech or Moderna.
Health Canada approved the Johnson & Johnson vaccine in March and updated its labelling last week to acknowledge the risk of a rare but serious blood-clotting condition connected to the shot known as vaccine-induced immune thrombotic thrombocytopenia (VITT).
Read more here